Business Context and Reporting Period
Company: Genmab A/S
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of April 2026
Filing Date: April 14, 2026
This filing serves as a procedural report to the U.S. Securities and Exchange Commission, incorporating by reference a Company Announcement dated April 14, 2026, and an Orbis Shareholder Notification.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet for exhibits and does not contain a financial statement or performance summary.
Material Changes
No material financial changes versus the prior comparable period are disclosed in the provided text. The filing references the inclusion of a shareholder notification and a company announcement but does not detail their specific content or financial impact.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It confirms that the report is incorporated by reference into specific Form S-8 registration statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Company Announcement Dated April 14, 2026) for the specific details of the corporate event.
- Review Exhibit 99.2 (Orbis Shareholder Notification) to understand the nature of the shareholder communication.
- Verify the impact of the announcement on the company's registration statements on Form S-8 (File Nos. 333-232693, 333-253519, 333-262970, 333-277273, 333-284876, and 333-293505).